Elite Clinical Research Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Novo Nordisk A/S2 trials
• Eli Lilly and Company1 trial

Running trials

• Not yet recruiting

  A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both

  NCT07931599· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Active, not recruiting

  A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

  NCT07076199· Phase 3· Novo Nordisk A/S· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 2 diabetes1 recruiting

Closed trials

• Withdrawn

  Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease

  NCT06598631· Phase 2· Eli Lilly and Company· Source